New & Noteworthy!

ACC Rockies Chapter Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.


For more information and to register, please visit: ACC Rockies Chapter Meeting 2026


ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Micro- and Nanoplastics Found in Patients With STEMI, CCS
    Levels of microplastics and nanoplastics (MNPs) in coronary blood were higher in patients with a STEMI than those with chronic coronary syndromes (CCS) or in controls, according to a cross-sectional study published July 14 in the EHJ.
  • Better Safety Profile, TR Reduction With T-TEER Than TTVA, Similar Outcomes at 1 Year
    In patients with severe secondary tricuspid regurgitation (TR), tricuspid valve transcatheter edge-to-edge repair (T-TEER), compared with transcatheter tricuspid valve annuloplasty (TTVA), showed a more favorable safety profile and a more effective and durable reduction in TR, while clinical outcomes at one year were similar with both strategies, according to research published July 22 in JACC: […]
  • CKM Syndrome Associated With Increased, Stage-Specific Cancer Risk
    Cardiovascular-kidney-metabolic (CKM) syndrome is associated with incremental cancer risk and stage-specific immune-metabolic pathways, according to a study using data from the UK Biobank published July 16 in JACC: CardioOncology. These findings highlight potential prevention targets.
  • If You Build It, Will They Come? Digital Health in AF Management
    Atrial fibrillation (AF) is the most common sustained arrhythmia in the United States, with a nation-wide prevalence projected to reach 12.1 million by 2030.1 AF is a major driver of adverse clinical outcomes, including stroke, dementia, myocardial infarction, sudden cardiac death, heart failure, chronic kidney disease, and all-cause death.
  • ACC CardiaCast: Beyond the Kidneys: UACR and Cardiovascular Risk
    Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with UACR as a biomarker.